Ilya Berim, MD
Pulmonary Disease · New Brunswick, NJNPI 1588801567
Payments from drug & device makers
Across 18 payments — averaging $226.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$4K
- Ambu Inc.$109
- Pulmonx Corporation$77
- Boston Scientific$53
- Medtronic$44
- Insmed, Inc.$14
What the payments were for
- Travel & lodging$1,26031%
- Food & beverage$3158%
- Education$2,50061%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 8 | $3,777 |
| Ambu Inc. | 1 | $109 |
| Pulmonx Corporation | 4 | $77 |
| Boston Scientific | 2 | $53 |
| Medtronic | 2 | $44 |
| Insmed, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$3,693
How this compares
$4,076 in reported general payments places this provider in the 60th percentile of 472 pulmonary disease providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OfevNintedanib Esylate | 12 | $139,427 |
| Dupixent PenDupilumab | 13 | $46,928 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 51 | $37,571 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 29 | $17,987 |
| Breo ElliptaFluticasone/Vilanterol | 15 | $7,526 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 11 | $2,133 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 12 | $1,829 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 59 | $1,590 |
| Ventolin HfaAlbuterol Sulfate | 11 | $610 |
| Fluticasone Propionate | 20 | $221 |
| Montelukast Sodium | 13 | $89 |
Paid to pharmacies, not to this prescriber.
Other pulmonary disease in New Brunswick
- Reynold PanettieriNew Brunswick$2.5M
- Sabina HussainNew Brunswick$555K
- Sugeet JagpalNew Brunswick$72K
- Amar BukhariNew Brunswick$36K
- Vinay SikandToms River$1.8M
- Stanley FielMorristown$1.3M
- Joseph HoffmanPark Ridge$1.1M
- Robert SussmanSummit$645K
- Ronaldo GoHackensack$563K
- Deborah GossHackensack$558K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.